NBS-C  BioScience 
Assay Development
NBS-C BioScience offers partnering in pre-clinical assay development for target identification and validation, e.g.

Characterization of monoclonal antibodies and other target binding molecules, recombinant cellular receptors and
ligands by 

-  purity assessment

-  determination of target specificity and affinity, epitope mapping
  
binding kinetics (SPR)

-  ELISA and SPR (Biacore) based concentration and potency assays

-  cell assays, DNA based assays and receptor binding assays

 

Transfer of preclinical research assays and procedures into GxP compliant qualified development tools will be pursued in collaboration with our GMP certified partner.